Status:
COMPLETED
Screening for Tuberculosis in Pregnancy
Lead Sponsor:
Queen Mary University of London
Collaborating Sponsors:
University College, London
City, University of London
Conditions:
Latent Tuberculosis
Eligibility:
FEMALE
16-35 years
Phase:
NA
Brief Summary
The UK has the second highest tuberculosis (TB) incidence in Western Europe. Most active cases occur in migrants due to reactivation of latent TB infection (LTBI) acquired abroad. Screening migrants f...
Detailed Description
The UK has the second-highest TB incidence in Western Europe. Most active TB cases occur in the non-UK born population (migrants) in large cities such as London. Migrants most at risk of TB are from c...
Eligibility Criteria
Inclusion
- All pregnant migrants aged 16-35 who have entered the UK less than 5 years ago from a country with a TB incidence of greater than 150/100,000 or sub-Saharan Africa
Exclusion
- Patients who do not meet the criteria for LTBI screening will be excluded which include:
- Previous history of TB or LTBI.
- Individuals who are unable to consent.
- Evidence of active TB (based on history, examination, blood tests, chest X-ray finding or other radiological findings).
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT04098341
Start Date
July 1 2019
End Date
May 31 2023
Last Update
July 8 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal London Hospital
London, Essex, United Kingdom, E1 1FR
2
Whipps Cross Hospital
London, Essex, United Kingdom, E11 1NR
3
Newham University Hospital
London, Essex, United Kingdom, E13 8SL